John Fain
Optometrist · Mesquite, TXNPI 1033268842
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.9%), speaking fees and gifts — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Alcon at 58.4% of the total. Reporting peaked in 2019 at $2,372 and has fallen 93.4% since, to $156 in 2024. Among optometrist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $59.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- Johnson & Johnson Vision Care, Inc.$524
- Bausch & Lomb, A Division Of Bausch Health US, LLC$491
- Bausch & Lomb Americas Inc.$466
- Aerie Pharmaceuticals, Inc.$272
- Glaukos Corporation$105
- plus $206 from 8 others
What the payments were for
- Speaking & faculty fees$2,00040%
- Food & beverage$2,92459%
- Gifts$371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 31 | $2,897 |
| Johnson & Johnson Vision Care, Inc. | 16 | $524 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 17 | $491 |
| Bausch & Lomb Americas Inc. | 4 | $466 |
| Aerie Pharmaceuticals, Inc. | 3 | $272 |
| Glaukos Corporation | 2 | $105 |
| AbbVie | 2 | $47 |
| LKC Technologies, Inc. | 1 | $39 |
| Eyevance Pharmaceuticals LLC | 2 | $28 |
| Novartis | 1 | $23 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Shire North American Group Inc | 1 | $19 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| Kala Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,961 in reported general payments places this provider in the 90th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 14 | $406 |
| Timolol Maleate | 13 | $96 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Mesquite
- Derek CunninghamAustin$940K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Luis RojasMcKinney$309K
- Emile FadelAustin$225K
- Bridgitte LeeHouston$222K
- Phillip BrunsonHouston$214K
- Jill AutryBellaire$171K
- Stacie VirdenWaco$164K
- Richard PotvinBurleson$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.